NYSE ARCA | ETF
The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 3.47% |
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 2.88% |
| CBAY | Cymabay Therapeu | Healthcare | Biotechnology | 2.88% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.87% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 2.80% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 2.75% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.61% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.51% |
| EWTX | Edgewise Therapeutics Inc | Healthcare | Biotechnology | 2.39% |
| CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.38% |
| PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 2.34% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 2.34% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 2.23% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 2.21% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.20% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 2.14% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.05% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 2.05% |
| TARS | Tarsus Pharmaceuticals Inc | Healthcare | Biotechnology | 1.96% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 1.80% |